CV Lattes
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Farmácia - HAbilitação Indústria from Universidade Federal de Minas Gerais (2006), master's at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2011), doctorate at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2014) and doctorate at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2011). Has experience in Pharmacy, focusing on Assurance and quality control of pharmaceuticals, acting on the following subjects: medicamentos, clae, darunavir, fluconazol and validação. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Darunavir is a protease inhibitor antiretroviral drug to HIV-1 widely used, the drug has activity even in cases of viral resistance to other antiretrovirals. Darunavir is a new drug and little studied. It is known that the drug presents polymorphism and its different polymorphic forms can convert between them depending on the climatic conditions of the environment. The dissolution rate of…
Darunavir is an antiretroviral drug, protease inhibitor of HIV-1 widely used. This drug has activity even in cases of viral resistance to other antiretroviral drugs. Darunavir is a new drug and little studied. There are no dissolution studies to darunavir raw material or finished product. Thus, we intend to develop discriminating dissolution method based on data from in vivo pharmacokinet…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |